Related Experiment Video
Updated: Apr 12, 2026
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
19.0K
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Bert A 't Hart1, Yvette van Kooyk2, Jeroen J G Geurts3
1Department of Immunobiology, Biomedical Primate Research Centre Rijswijk, The Netherlands ; Department Neuroscience, University Medical Center, University of Groningen Groningen, The Netherlands.
Annals of Clinical and Translational Neurology
|May 23, 2015
Summary
Studying nonhuman primate EAE models, particularly in marmosets, offers new insights into multiple sclerosis (MS) treatment paradoxes. These models help bridge the gap between mouse studies and human MS therapies.
Area of Science:
- Neuroimmunology
- Translational Medicine
Background:
- Multiple sclerosis (MS) is an autoimmune CNS disorder with unknown causes and limited treatments.
- Translating mouse experimental autoimmune encephalomyelitis (EAE) findings to human MS therapies is challenging due to species differences.
Purpose of the Study:
- To explore how nonhuman primate EAE (NHP-EAE) models can illuminate the mechanistic basis of the therapy paradox in MS.
- To highlight the utility of the common marmoset (Callithrix jacchus) EAE model.
Main Methods:
- Review of existing data on NHP-EAE models.
- Comparative analysis of immunological and pathological features between mouse EAE, NHP-EAE, and human MS.
Main Results:
- NHP-EAE models exhibit significant immunological and pathological similarities to human MS.
- These models provide a closer parallel to human disease than traditional mouse models.
Conclusions:
- Nonhuman primate EAE models are valuable tools for bridging the translational gap in MS research.
- Studying NHP-EAE can lead to a better understanding of MS pathogenesis and inform the development of effective therapies.
